Rewiring cell polarity signaling in cancer

Oncogene

Volumn 34, Issue 8, 2015, Pages 939-950

  Halaoui, R ^a,b   McCaffrey, L ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CRB1 PROTEIN, HUMAN; EYE PROTEIN; JTB PROTEIN, HUMAN; MEMBRANE PROTEIN; NERVE PROTEIN; SCRIB PROTEIN, HUMAN; TUMOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ANIMAL; CELL POLARITY; CELL TRANSFORMATION; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENETICS; HUMAN; METASTASIS; NEOPLASMS; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR INVASION;

ANIMALS; CELL POLARITY; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; EYE PROTEINS; HUMANS; MEMBRANE PROTEINS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASMS; NERVE TISSUE PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84895915081     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.59     Document Type: Review

References (210)

1. Nelson WJ, Dickinson DJ, Weis WI. Roles of cadherins and catenins in cell-cell adhesion and epithelial cell polarity. Progr Mol Biol Transl Sci 2013; 116: 3-23.
2. Carthew RW. Adhesion proteins and the control of cell shape. Curr Opin Genet Dev 2005; 15: 358-363.
3. Martin-Belmonte F, Mostov K. Regulation of cell polarity during epithelial morphogenesis. Curr Opin Cell Biol 2008; 20: 227-234.
4. McCaffrey LM, Macara IG. Epithelial organization, cell polarity and tumorigenesis. Trends Cell Biol 2011; 21: 727-735.
5. Nance J, Zallen JA. Elaborating polarity: PAR proteins and the cytoskeleton. Development 2011; 138: 799-809.
6. St Johnston D, Ahringer J. Cell polarity in eggs and epithelia: parallels and diversity. Cell 2010; 141: 757-774.
7. Tepass U. The apical polarity protein network in Drosophila epithelial cells: regulation of polarity, junctions, morphogenesis, cell growth, and survival. Annu Rev Cell Dev Biol 2012; 28: 655-685.
8. Martin-Belmonte F, Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 2011; 12: 23-38.
9. Jansen M, Ten Klooster JP, Offerhaus GJ, Clevers H. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism. Physiol Rev 2009; 89: 777-798.
10. Laprise P, Tepass U. Novel insights into epithelial polarity proteins in Drosophila. Trends Cell Biol 2011; 21: 401-408.
11. Bostwick DG, Cheng L. Precursors of prostate cancer. Histopathology 2012; 60: 4-27.
12. Siziopikou KP. Ductal carcinoma in situ of the breast. Arch Pathol Lab Med 2013; 137: 462-466.
13. Pocha SM, Knust E. Complexities of Crumbs function and regulation in tissue morphogenesis. Curr Biol 2013; 23: R289-R293.
14. Laprise P. Emerging role for epithelial polarity proteins of the Crumbs family as potential tumor suppressors. J Biomed Biotechnol 2011; 2011: 868217.
15. McCaffrey LM, Macara IG. Signaling pathways in cell polarity. Cold Spring Harbor Perspect Biol 2012; 4: a009654.
16. Goldstein B, Macara IG. The PAR proteins: fundamental players in animal cell polarization. Dev Cell 2007; 13: 609-622.
17. Ebnet K, Suzuki A, Horikoshi Y, Hirose T, Meyer Zu BMK, Ohno S et al. The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). EMBO J 2001; 20: 3738-3748.
18. Krahn MP, Klopfenstein DR, Fischer N, Wodarz A. Membrane targeting of Bazooka/PAR-3 is mediated by direct binding to phosphoinositide lipids. Curr Biol 2010; 20: 636-642.
19. Durgan J, Kaji N, Jin D, Hall A. Par6B and atypical PKC regulate mitotic spindle orientation during epithelial morphogenesis. J Biol Chem 2011; 286: 12461-12474.
20. Morais-de-Sa E, Mirouse V, St Johnston D. aPKC phosphorylation of Bazooka defines the apical/lateral border in Drosophila epithelial cells. Cell 2010; 141: 509-523.
21. Hayase J, Kamakura S, Iwakiri Y, Yamaguchi Y, Izaki T, Ito T et al. The WD40 protein Morg1 facilitates Par6-a PKC binding to Crb3 for apical identity in epithelial cells. J Cell Biol 2013; 200: 635-650.
22. Hurd TW, Gao L, Roh MH, Macara IG, Margolis B. Direct interaction of two polarity complexes implicated in epithelial tight junction assembly. Nat Cell Biol 2003; 5: 137-142.
23. Benton R, St Johnston D. Drosophila PAR-1 and 14-3-3 inhibit Bazooka/PAR-3 to establish complementary cortical domains in polarized cells. Cell 2003; 115: 691-704.
24. Yang Z, Xue B, Umitsu M, Ikura M, Muthuswamy SK, Neel BG. The signaling adaptor GAB1 regulates cell polarity by acting as a PAR protein scaffold. Mol Cell 2012; 47: 469-483.
25. Hurov J, Piwnica-Worms H. The Par-1/MARK family of protein kinases: from polarity to metabolism. Cell Cycle 2007; 6: 1966-1969.
26. Suzuki A, Hirata M, Kamimura K, Maniwa R, Yamanaka T, Mizuno K et al. aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity. Curr Biol 2004; 14: 1425-1435.
27. Plant PJ, Fawcett JP, Lin DC, Holdorf AD, Binns K, Kulkarni S et al. A polarity complex of mPar-6 and atypical PKC binds, phosphorylates and regulates mammalian Lgl. Nat Cell Biol 2003; 5: 301-308.
28. Smith CA, Lau KM, Rahmani Z, Dho SE, Brothers G, She YM et al. aPKC-mediated phosphorylation regulates asymmetric membrane localization of the cell fate determinant Numb. EMBO J 2007; 26: 468-480.
29. Yoshihama Y, Sasaki K, Horikoshi Y, Suzuki A, Ohtsuka T, Hakuno F et al. KIBRA suppresses apical exocytosis through inhibition of aPKC kinase activity in epithelial cells. Curr Biol 2011; 21: 705-711.
30. Joberty G, Petersen C, Gao L, Macara IG. The cell-polarity protein Par6 links Par3 and atypical protein kinase C to Cdc42. Nat Cell Biol 2000; 2: 531-539.
31. Humbert PO, Dow LE, Russell SM. The Scribble and Par complexes in polarity and migration: friends or foes? Trends Cell Biol 2006; 16: 622-630.
32. Qin Y, Capaldo C, Gumbiner BM, Macara IG. The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol 2005; 171: 1061-1071.
33. Navarro C, Nola S, Audebert S, Santoni MJ, Arsanto JP, Ginestier C et al. Junctional recruitment of mammalian Scribble relies on E-cadherin engagement. Oncogene 2005; 24: 4330-4339.
34. Bilder D, Perrimon N. Localization of apical epithelial determinants by the basolateral PDZ protein Scribble. Nature 2000; 403: 676-680.
35. Gustafson WC, Ray S, Jamieson L, Thompson EA, Brasier AR, Fields AP. Bcr-Abl regulates protein kinase Ciota (PKCiota) transcription via an Elk1 site in the PKCiota promoter. J Biol Chem 2004; 279: 9400-9408.
36. Atwood SX, Li M, Lee A, Tang JY, Oro AE. GLI activation by atypical protein kinase C -/- regulates the growth of basal cell carcinomas. Nature 2013; 494: 484-488.
37. Russ A, Louderbough JM, Zarnescu D, Schroeder JA. Hugl1 and Hugl2 in mammary epithelial cells: polarity, proliferation, and differentiation. PLoS One 2012; 7: e47734.
38. Kashyap A, Zimmerman T, Ergül N, Bosserhoff A, Hartman U, Alla V et al. The human Lgl polarity gene, Hugl-2, induces MET and suppresses Snail tumorigenesis. Oncogene 2012; 32: 1396-1407.
39. Elsum IA, Humbert PO. Localization, not important in all tumor-suppressing properties: a lesson learnt from scribble. Cells Tissues Organs 2013; 198: 1-11.
40. Zhan L, Rosenberg A, Bergami KC, Yu M, Xuan Z, Jaffe AB et al. Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 2008; 135: 865-878.
41. Rothenberg SM, Mohapatra G, Rivera MN, Winokur D, Greninger P, Nitta M et al. A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers. Cancer Res 2010; 70: 2158-2164.
42. Linch M, Sanz-Garcia M, Rosse C, Riou P, Peel N, Madsen C et al. Regulation of polarized morphogenesis by protein kinase C iota in oncogenic epithelial spheroids. Carcinogenesis 2013; 35: 396-406.
43. Galvez AS, Duran A, Linares JF, Pathrose P, Castilla EA, Abu-Baker S et al. Protein kinase Czeta represses the interleukin-6 promoter and impairs tumorigenesis in vivo. Mol Cell Biol 2009; 29: 104-115.
44. Bergstralh DT, St Johnston D. Epithelial cell polarity: what flies can teach us about cancer. Essays Biochem 2012; 53: 129-140.
45. Elsum I, Yates L, Humbert PO, Richardson HE. The Scribble-Dlg-Lgl polarity module in development and cancer: from flies to man. Essays Biochem 2012; 53: 141-168.
46. Vidal M, Cagan RL. Drosophila models for cancer research. Curr Opin Genet Dev 2006; 16: 10-16.
47. Fan Y, Bergmann A. Apoptosis-induced compensatory proliferation. The cell is dead. Long live the cell. Trends Cell Biol 2008; 18: 467-473.
48. Levayer R, Moreno E. Mechanisms of cell competition: themes and variations. J Cell Biol 2013; 200: 689-698.
49. Pearson HB, Perez-Mancera PA, Dow LE, Ryan A, Tennstedt P, Bogani D et al. SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia. J Clin Invest 2011; 121: 4257-4267.
50. Klezovitch O, Fernandez TE, Tapscott SJ, Vasioukhin V. Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice. Genes Dev 2004; 18: 559-571.
51. McCaffrey LM, Macara IG. The Par3/aPKC interaction is essential for end bud remodeling and progenitor differentiation during mammary gland morphogenesis. Genes Dev 2009; 23: 1450-1460.
52. Knoblich JA. Asymmetric cell division: recent developments and their implications for tumour biology. Nat Revi Mol Cell Biol 2010; 11: 849-860.
53. Du Q, Macara IG. Mammalian Pins is a conformational switch that links NuMA to heterotrimeric G proteins. Cell 2004; 119: 503-516.
54. Du Q, Stukenberg PT, Macara IG. A mammalian Partner of inscuteable binds NuMA and regulates mitotic spindle organization. Nat Cell Biol 2001; 3: 1069-1075.
55. Hao Y, Du Q, Chen X, Zheng Z, Balsbaugh JL, Maitra S et al. Par3 controls epithelial spindle orientation by aPKC-mediated phosphorylation of apical pins. Curr Biol 2010; 20: 1809-1818.
56. Jaffe AB, Kaji N, Durgan J, Hall A. Cdc42 controls spindle orientation to position the apical surface during epithelial morphogenesis. J Cell Biol 2008; 183: 625-633.
57. Qin Y, Meisen WH, Hao Y, Macara IG. Tuba, a Cdc42 GEF, is required for polarized spindle orientation during epithelial cyst formation. J Cell Biol 2010; 189: 661-669.
58. Lazaro-Dieguez F, Cohen D, Fernandez D, Hodgson L, van Ijzendoorn SC, Musch A. Par1b links lumen polarity with LGN-NuMA positioning for distinct epithelial cell division phenotypes. J Cell Biol 2013; 203: 251-264.
59. Bergstralh DT, Lovegrove HE, St Johnston D. Discs large links spindle orientation to apical-basal polarity in Drosophila epithelia. Curr Biol 2013; 23: 1707-1712.
60. Nakajima Y, Meyer EJ, Kroesen A, McKinney SA, Gibson MC. Epithelial junctions maintain tissue architecture by directing planar spindle orientation. Nature 2013; 500: 359-362.
61. Herrmann JL, Byekova Y, Elmets CA, Athar M. Liver kinase B1 (LKB1) in the pathogenesis of epithelial cancers. Cancer Lett 2011; 306: 1-9.
62. Beggs AD, Latchford AR, Vasen HF, Moslein G, Alonso A, Aretz S et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut 2010; 59: 975-986.
63. Bardeesy N, Sinha M, Hezel AF, Signoretti S, Hathaway NA, Sharpless NE et al. Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature 2002; 419: 162-167.
64. McCarthy A, Lord CJ, Savage K, Grigoriadis A, Smith DP, Weigelt B et al. Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formation. J Pathol 2009; 219: 306-316.
65. Lo B, Strasser G, Sagolla M, Austin CD, Junttila M, Mellman I. Lkb1 regulates organogenesis and early oncogenesis along AMPK-dependent and-independent pathways. J Cell Biol 2012; 199: 1117-1130.
66. Partanen JI, Tervonen TA, Myllynen M, Lind E, Imai M, Katajisto P et al. Tumor suppressor function of Liver kinase B1 (Lkb1) is linked to regulation of epithelial integrity. Proc Natl Acad Sci 2012; 109: E388-E397.
67. Andrade-Vieira R, Xu Z, Colp P, Marignani PA. Loss of LKB1 expression reduces the latency of ErbB2-mediated mammary gland tumorigenesis, promoting changes in metabolic pathways. PLoS One 2013; 8: e56567.
68. Briscoe J, Therond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol 2013; 14: 416-429.
69. Zhuang Z, Wang K, Cheng X, Qu X, Jiang B, Li Z et al. LKB1 inhibits breast cancer partially through repressing the hedgehog signaling pathway. PLoS One 2013; 8: e67431.
70. Murray NR, Kalari KR, Fields AP. Protein kinase Ciota expression and oncogenic signaling mechanisms in cancer. J Cell Physiol 2011; 226: 879-887.
71. Callahan CA, Ofstad T, Horng L, Wang JK, Zhen HH, Coulombe PA et al. MIM/BEG4, a Sonic hedgehog-responsive gene that potentiates Gli-dependent transcription. Genes Dev 2004; 18: 2724-2729.
72. Geisbrecht ER, Sawant K, Su Y, Liu ZC, Silver DL, Burtscher A et al. Genetic interaction screens identify a role for hedgehog signaling in Drosophila border cell migration. Dev Dyn 2013; 242: 414-431.
73. Park TJ, Mitchell BJ, Abitua PB, Kintner C, Wallingford JB. Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells. Nat Genet 2008; 40: 871-879.
74. Hashizume A, Hieda Y. Hedgehog peptide promotes cell polarization and lumen formation in developing mouse submandibular gland. Biochem Biophys Res Commun 2006; 339: 996-1000.
75. Kosinski C, Stange DE, Xu C, Chan AS, Ho C, Yuen ST et al. Indian hedgehog regulates intestinal stem cell fate through epithelial-mesenchymal interactions during development. Gastroenterology 2010; 139: 893-903.
76. Krauss S, Concordet JP, Ingham PW. A functionally conserved homolog of the Drosophila segment polarity gene hh is expressed in tissues with polarizing activity in zebrafish embryos. Cell 1993; 75: 1431-1444.
77. Murray NR, Jamieson L, Yu W, Zhang J, Gokmen-Polar Y, Sier D et al. Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo. J Cell Biol 2004; 164: 797-802.
78. Regala RP, Weems C, Jamieson L, Copland JA, Thompson EA, Fields AP. Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem 2005; 280: 31109-31115.
79. Wang Y, Hill KS, Fields AP. Protein kinase C maintains a tumor-initiating cell phenotype that is required for ovarian tumorigenesis. Mol Cancer Res 2013; 11: 1624-1635.
80. Justilien V, Jameison L, Der CJ, Rossman KL, Fields AP. Oncogenic activity of Ect2 is regulated through protein kinase C iota-mediated phosphorylation. J Biol Chem 2011; 286: 8149-8157.
81. Justilien V, Fields AP. Ect2 links the PKCiota-Par6alpha complex to Rac1 activation and cellular transformation. Oncogene 2009; 28: 3597-3607.
82. Kim JY, Valencia T, Abu-Baker S, Linares J, Lee SJ, Yajima T et al. c-Myc phosphorylation by PKCzeta represses prostate tumorigenesis. Proc Natl Acad Sci USA 2013; 110: 6418-6423.
83. Powell CT, Gschwend JE, Fair WR, Brittis NJ, Stec D, Huryk R. Overexpression of protein kinase C-zeta (PKC-zeta) inhibits invasive and metastatic abilities of Dunning R-3327 MAT-LyLu rat prostate cancer cells. Cancer Res 1996; 56: 4137-4141.
84. Ma L, Tao Y, Duran A, Llado V, Galvez A, Barger Jennifer F et al. Control of nutrient stress-induced metabolic reprogramming by PKC in tumorigenesis. Cell 2013; 152: 599-611.
85. Nagasaka K, Pim D, Massimi P, Thomas M, Tomaic V, Subbaiah VK et al. The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction. Oncogene 2010; 29: 5311-5321.
86. Anastas JN, Biechele TL, Robitaille M, Muster J, Allison KH, Angers S et al. A protein complex of SCRIB, NOS1AP and VANGL1 regulates cell polarity and migration, and is associated with breast cancer progression. Oncogene 2012; 31: 3696-3708.
87. Richier L, Williton K, Clattenburg L, Colwill K, O'Brien M, Tsang C et al. NOS1AP associates with Scribble and regulates dendritic spine development. J Neurosci 2010; 30: 4796-4805.
88. Dow LE, Elsum IA, King CL, Kinross KM, Richardson HE, Humbert PO. Loss of human Scribble cooperates with H-Ras to promote cell invasion through deregulation of MAPK signalling. Oncogene 2008; 27: 5988-6001.
89. Iden S, van Riel Wilhelmina E, Schäfer R, Song J-Y, Hirose T, Ohno S et al. Tumor type-dependent function of the Par3 polarity protein in skin tumorigenesis. Cancer Cell 2012; 22: 389-403.
90. McCaffrey LM, Montalbano J, Mihai C, Macara IG. Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis. Cancer Cell 2012; 22: 601-614.
91. Aragona M, Panciera T, Manfrin A, Giulitti S, Michielin F, Elvassore N et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 2013; 154: 1047-1059.
92. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70.
93. Bao Y, Hata Y, Ikeda M, Withanage K. Mammalian Hippo pathway: from development to cancer and beyond. J Biochem 2011; 149: 361-379.
94. Boggiano JC, Fehon RG. Growth control by committee: intercellular junctions, cell polarity, and the cytoskeleton regulate Hippo signaling. Dev Cell 2012; 22: 695-702.
95. Lin JI, Poon CL, Harvey KF. The Hippo size control pathway - ever expanding. Sci Signal 2013; 6: pe4.
96. Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol 2011; 13: 877-883.
97. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 2011; 144: 782-795.
98. Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei Q et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev 2011; 25: 51-63.
99. Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, Cockburn K, Larsen BG et al. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev Cell 2010; 19: 831-844.
100. Karp CM, Tan TT, Mathew R, Nelson D, Mukherjee C, Degenhardt K et al. Role of the polarity determinant crumbs in suppressing mammalian epithelial tumor progression. Cancer Res 2008; 68: 4105-4115.
101. Yin F, Yu J, Zheng Y, Chen Q, Zhang N, Pan D. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell 2013; 154: 1342-1355.
102. Moleirinho S, Chang N, Sims AH, Tilston-Lunel AM, Angus L, Steele A et al. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals. Oncogene 2013; 32: 1821-1830.
103. Xiao L, Chen Y, Ji M, Dong J. KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases. J Biol Chem 2011; 286: 7788-7796.
104. Cordenonsi M, Zanconato F, Azzolin L, Forcato M, Rosato A, Frasson C et al. The Hippo transducer TAZ Confers cancer stem cell-related traits on breast cancer cells. Cell 2011; 147: 759-772.
105. Hanahan D, Weinberg Robert A. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
106. Dang CV. Links between metabolism and cancer. Genes Dev 2012; 26: 877-890.
107. Shackelford DB, Shaw RJ. The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 2009; 9: 563-575.
108. Lee JH, Koh H, Kim M, Kim Y, Lee SY, Karess RE et al. Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 2007; 447: 1017-1020.
109. Zhang L, Li J, Young LH, Caplan MJ. AMP-activated protein kinase regulates the assembly of epithelial tight junctions. Proc Natl Acad Sci USA 2006; 103: 17272-17277.
110. Shaw RJ, Bardeesy N, Manning BD, Lopez L, Kosmatka M, DePinho RA et al. The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell 2004; 6: 91-99.
111. Stefanatos RKA, Vidal M. Tumor invasion and metastasis in Drosophila: a bold past, a bright future. J Genet Genom 2011; 38: 431-438.
112. Pagliarini RA, Xu T. A genetic screen in Drosophila for metastatic behavior. Science 2003; 302: 1227-1231.
113. Ocaña Oscar H, Córcoles R, Fabra Á, Moreno-Bueno G, Acloque H, Vega S et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 2012; 22: 709-724.
114. Tsai Jeff H, Donaher Joana L, Murphy Danielle A, Chau S, Yang J. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012; 22: 725-736.
115. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-890.
116. Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2009; 188: 11-19.
117. Nguyen-Ngoc KV, Cheung KJ, Brenot A, Shamir ER, Gray RS, Hines WC et al. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc Natl Acad Sci USA 2012; 109: E2595-E2604.
118. Ewald AJ, Huebner RJ, Palsdottir H, Lee JK, Perez MJ, Jorgens DM et al. Mammary collective cell migration involves transient loss of epithelial features and individual cell migration within the epithelium. J Cell Sci 2012; 125: 2638-2654.
119. Yu M, Bardia A, Wittner BS, Stott SL, Smas ME, Ting DT et al. Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science 2013; 339: 580-584.
120. Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M et al. The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 2007; 26: 6979-6988.
121. Elsum IA, Martin C, Humbert PO. Scribble regulates an EMT polarity pathway through modulation of MAPK-ERK signaling to mediate junction formation. J Cell Sci 2013; 126: 3990-3999.
122. Chatterjee S, Seifried L, Feigin ME, Gibbons DL, Scuoppo C, Lin W et al. Dysregulation of cell polarity proteins synergize with oncogenes or the microenvironment to induce invasive behavior in epithelial cells. PLoS One 2012; 7: e34343.
123. Xue B, Krishnamurthy K, Allred DC, Muthuswamy SK. Loss of Par3 promotes breast cancer metastasis by compromising cell-cell cohesion. Nat Cell Biol 2012; 15: 189-200.
124. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, Wrana JL. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 2005; 307: 1603-1609.
125. Viloria-Petit AM, Wrana JL. The TGFbeta-Par6 polarity pathway: linking the Par complex to EMT and breast cancer progression. Cell Cycle 2010; 9: 623-624.
126. Gunaratne A, Di Guglielmo GM. Par6 is phosphorylated by aPKC to facilitate EMT. Cell Adhes Migr 2013; 7: 357-361.
127. Aranda V, Haire T, Nolan ME, Calarco JP, Rosenberg AZ, Fawcett JP et al. Par6-a PKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat Cell Biol 2006; 8: 1235-1245.
128. Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z. Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. Dev Cell 2008; 14: 570-581.
129. Brabletz S, Brabletz T. The ZEB/miR-200 feedback loop - a motor of cellular plasticity in development and cancer? EMBO Rep 2010; 11: 670-677.
130. Nagaoka K, Zhang H, Watanabe G, Taya K. Epithelial cell differentiation regulated by MicroRNA-200a in mammary glands. PLoS One 2013; 8: e65127.
131. Bambang IF, Lee YK, Richardson DR, Zhang D. Endoplasmic reticulum protein 29 regulates epithelial cell integrity during the mesenchymal-epithelial transition in breast cancer cells. Oncogene 2013; 32: 1240-1251.
132. Friedl P, Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009; 10: 445-457.
133. Friedl P, Wolf K. Plasticity of cell migration: a multiscale tuning model. J Cell Biol 2010; 188: 11-19.
134. Hidalgo-Carcedo C, Hooper S, Chaudhry SI, Williamson P, Harrington K, Leitinger B et al. Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat Cell Biol 2011; 13: 49-58.
135. Viloria-Petit AM, David L, Jia JY, Erdemir T, Bane AL, Pinnaduwage D et al. A role for the TGFbeta-Par6 polarity pathway in breast cancer progression. Proc Natl Acad Sci UsA 2009; 106: 14028-14033.
136. O'Brien LE, Jou TS, Pollack AL, Zhang Q, Hansen SH, Yurchenco P et al. Rac1 orientates epithelial apical polarity through effects on basolateral laminin assembly. Nat Cell Biol 2001; 3: 831-838.
137. Weaver VM, Howlett AR, Langton-Webster B, Petersen OW, Bissell MJ. The development of a functionally relevant cell culture model of progressive human breast cancer. Semin Cancer Biol 1995; 6: 175-184.
138. Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW. The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 2002; 70: 537-546.
139. Yu W, Datta A, Leroy P, O'Brien LE, Mak G, Jou TS et al. Beta1-integrin orients epithelial polarity via Rac1 and laminin. Mol Biol Cell 2005; 16: 433-445.
140. Akhtar N, Streuli CH. An integrin-ILK-microtubule network orients cell polarity and lumen formation in glandular epithelium. Nat Cell Biol 2012; 15: 17-27.
141. Frederick LA, Matthews JA, Jamieson L, Justilien V, Thompson EA, Radisky DC et al. Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer. Oncogene 2008; 27: 4841-4853.
142. Al-Saad S, Al-Shibli K, Donnem T, Persson M, Bremnes RM, Busund LT. The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer. Br J Cancer 2008; 99: 1476-1483.
143. Solinet S, Akpovi CD, Garcia CJ, Barry A, Vitale ML. Myosin IIB deficiency in embryonic fibroblasts affects regulators and core members of the par polarity complex. Histochem Cell Biol 2011; 136: 245-266.
144. Wang HR, Zhang Y, Ozdamar B, Ogunjimi AA, Alexandrova E, Thomsen GH et al. Regulation of cell polarity and protrusion formation by targeting RhoA for degradation. Science 2003; 302: 1775-1779.
145. Schmoranzer J, Fawcett JP, Segura M, Tan S, Vallee RB, Pawson T et al. Par3 and dynein associate to regulate local microtubule dynamics and centrosome orientation during migration. Curr Biol 2009; 19: 1065-1074.
146. Petit MM, Meulemans SM, Alen P, Ayoubi TA, Jansen E, Van de Ven WJ. The tumor suppressor Scrib interacts with the zyxin-related protein LPP, which shuttles between cell adhesion sites and the nucleus. BMC Cell Biol 2005; 6: 1.
147. Allen WE, Zicha D, Ridley AJ, Jones GE. A role for Cdc42 in macrophage chemotaxis. J Cell Biol 1998; 141: 1147-1157.
148. Liu Q, Ning W, Dantzer R, Freund GG, Kelley KW. Activation of protein kinase C-zeta and phosphatidylinositol 30-kinase and promotion of macrophage differentiation by insulin-like growth factor-I. J Immunol 1998; 160: 1393-1401.
149. Tamehiro N, Mujawar Z, Zhou S, Zhuang DZ, Hornemann T, von Eckardstein A et al. Cell polarity factor Par3 binds SPTLC1 and modulates monocyte serine palmitoyltransferase activity and chemotaxis. J Biol Chem 2009; 284: 24881-24890.
150. Soltanian S, Matin MM. Cancer stem cells and cancer therapy. Tumour Biol 2011; 32: 425-440.
151. Visvader JE, Lindeman GJ. Cancer stem cells: current status and evolving complexities. Cell Stem Cell 2012; 10: 717-728.
152. Zen K, Yasui K, Gen Y, Dohi O, Wakabayashi N, Mitsufuji S et al. Defective expression of polarity protein PAR-3 gene (PARD3) in esophageal squamous cell carcinoma. Oncogene 2009; 28: 2910-2918.
153. Dugay F, Goff XL, Rioux-Leclerq N, Chesnel F, Jouan F, Henry C et al. Overexpression of the polarity protein PAR-3 in clear cell renal cell carcinoma is associated with poor prognosis. Int J Cancer 2013; 134: 251-260.
154. Cunliffe HE, Jiang Y, Fornace KM, Yang F, Meltzer PS. PAR6B is required for tight junction formation and activated PKCzeta localization in breast cancer. Am J Cancer Res 2012; 2: 478-491.
155. Nolan ME, Aranda V, Lee S, Lakshmi B, Basu S, Allred DC et al. The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer. Cancer Res 2008; 68: 8201-8209.
156. Tsai JH, Hsieh YS, Kuo SJ, Chen ST, Yu SY, Huang CY et al. Alteration in the expression of protein kinase C isoforms in human hepatocellular carcinoma. Cancer Lett 2000; 161: 171-175.
157. Langzam L, Koren R, Gal R, Kugel V, Paz A, Farkas A et al. Patterns of protein kinase C isoenzyme expression in transitional cell carcinoma of bladder. Relation to degree of malignancy. Am J Clin Pathol 2001; 116: 377-385.
158. Cohen EE, Lingen MW, Zhu B, Zhu H, Straza MW, Pierce C et al. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase. Cancer Res 2006; 66: 6296-6303.
159. Evans JD, Cornford PA, Dodson A, Neoptolemos JP, Foster CS. Expression patterns of protein kinase C isoenzymes are characteristically modulated in chronic pancreatitis and pancreatic cancer. Am J Clin Pathol 2003; 119: 392-402.
160. Yao S, Bee A, Brewer D, Dodson A, Beesley C, Ke Y et al. PRKC-zeta expression promotes the aggressive phenotype of human prostate cancer cells and is a novel target for therapeutic intervention. Genes Cancer 2010; 1: 444-464.
161. Yao S, Ireland SJ, Bee A, Beesley C, Forootan SS, Dodson A et al. Splice variant PRKC-zeta(-PrC) is a novel biomarker of human prostate cancer. Br J Cancer 2012; 107: 388-399.
162. Namdarian B, Wong E, Galea R, Pedersen J, Chin X, Speirs R et al. Loss of APKC expression independently predicts tumor recurrence in superficial bladder cancers. Urol Oncol 2013; 31: 649-655.
163. Grifoni D, Garoia F, Bellosta P, Parisi F, De Biase D, Collina G et al. aPKCzeta cortical loading is associated with Lgl cytoplasmic release and tumor growth in Drosophila and human epithelia. Oncogene 2007; 26: 5960-5965.
164. Du GS, Wang JM, Lu JX, Li Q, Ma CQ, Du JT et al. Expression of P-a PKC-iota, E-cadherin, and beta-catenin related to invasion and metastasis in hepatocellular carcinoma. Ann Surg Oncol 2009; 16: 1578-1586.
165. Regala RP, Weems C, Jamieson L, Khoor A, Edell ES, Lohse CM et al. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer research, 2005; 65: 8905-8911.
166. Kato S, Akimoto K, Nagashima Y, Ishiguro H, Kubota K, Kobayashi N et al. aPKClambda/ iota is a beneficial prognostic marker for pancreatic neoplasms. Pancreatology 2013; 13: 360-368.
167. Eder AM, Sui X, Rosen DG, Nolden LK, Cheng KW, Lahad JP et al. Atypical PKCiota contributes to poor prognosis through loss of apical-basal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci USA 2005; 102: 12519-12524.
168. Yang YL, Chu JY, Luo ML, Wu YP, Zhang Y, Feng YB et al. Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma. Genes Chromosomes Cancer 2008; 47: 127-136.
169. Kohjima M, Noda Y, Takeya R, Saito N, Takeuchi K, Sumimoto H. PAR3beta, a novel homologue of the cell polarity protein PAR3, localizes to tight junctions. Biochem Biophys Res Commun 2002; 299: 641-646.
170. Gardiol D, Zacchi A, Petrera F, Stanta G, Banks L. Human discs large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissue architecture during malignant progression. Int J Cancer 2006; 119: 1285-1290.
171. Nakagawa S, Yano T, Nakagawa K, Takizawa S, Suzuki Y, Yasugi T et al. Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix. Br J Cancer 2004; 90: 194-199.
172. Ouyang Z, Zhan W, Dan L. hScrib, a human homolog of Drosophila neoplastic tumor suppressor, is involved in the progress of endometrial cancer. Oncol Res 2010; 18: 593-599.
173. Gardiol D, Kuhne C, Glaunsinger B, Lee SS, Javier R, Banks L. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 1999; 18: 5487-5496.
174. Lin HT, Steller MA, Aish L, Hanada T, Chishti AH. Differential expression of human Dlg in cervical intraepithelial neoplasias. Gynecol Oncol 2004; 93: 422-428.
175. Watson RA, Rollason TP, Reynolds GM, Murray PG, Banks L, Roberts S. Changes in expression of the human homologue of the Drosophila discs large tumour suppressor protein in high-grade premalignant cervical neoplasias. Carcinogenesis 2002; 23: 1791-1796.
176. Cavatorta AL, Fumero G, Chouhy D, Aguirre R, Nocito AL, Giri AA et al. Differential expression of the human homologue of drosophila discs large oncosuppressor in histologic samples from human papillomavirus-associated lesions as a marker for progression to malignancy. Int J Cancer 2004; 111: 373-380.
177. Zubakov D, Stupar Z, Kovacs G. Differential expression of a new isoform of DLG2 in renal oncocytoma. BMC Cancer 2006; 6: 106.
178. Feng X, Chen K, Ye S, Wang H, Wei G, Tan W et al. MPP3 inactivation by promoter CpG islands hypermethylation in colorectal carcinogenesis. Cancer Biomarkers 2012; 11: 99-106.
179. Grifoni D, Garoia F, Schimanski CC, Schmitz G, Laurenti E, Galle PR et al. The human protein Hugl-1 substitutes for Drosophila lethal giant larvae tumour suppressor function in vivo. Oncogene 2004; 23: 8688-8694.
180. Schimanski CC, Schmitz G, Kashyap A, Bosserhoff AK, Bataille F, Schafer SC et al. Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene 2005; 24: 3100-3109.
181. Kuphal S, Wallner S, Schimanski CC, Bataille F, Hofer P, Strand S et al. Expression of Hugl-1 is strongly reduced in malignant melanoma. Oncogene 2006; 25: 103-110.
182. Lu X, Feng X, Man X, Yang G, Tang L, Du D et al. Aberrant splicing of Hugl-1 is associated with hepatocellular carcinoma progression. Clin Cancer Res 2009; 15: 3287-3296.
183. Lisovsky M, Dresser K, Baker S, Fisher A, Woda B, Banner B et al. Cell polarity protein Lgl2 is lost or aberrantly localized in gastric dysplasia and adenocarcinoma: an immunohistochemical study. Mod Pathol 2009; 22: 977-984.
184. Lisovsky M, Ogawa F, Dresser K, Woda B, Lauwers GY. Loss of cell polarity protein Lgl2 in foveolar-type gastric dysplasia: correlation with expression of the apical marker aPKC-zeta. Virchows Archiv 2010; 457: 635-642.
185. Tsuruga T, Nakagawa S, Watanabe M, Takizawa S, Matsumoto Y, Nagasaka K et al. Loss of Hugl-1 expression associates with lymph node metastasis in endometrial cancer. Oncol Res 2007; 16: 431-435.
186. Storrs CH, Silverstein SJ. PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6. J Virol 2007; 81: 4080-4090.
187. Korsse SE, Biermann K, Offerhaus GJ, Wagner A, Dekker E, Mathus-Vliegen EM et al. Identification of molecular alterations in gastrointestinal carcinomas and dysplastic hamartomas in Peutz-Jeghers syndrome. Carcinogenesis 2013; 34: 1611-1619.
188. Park WS, Moon YW, Yang YM, Kim YS, Kim YD, Fuller BG et al. Mutations of the STK11 gene in sporadic gastric carcinoma. Int J Oncol 1998; 13: 601-604.
189. Avizienyte E, Roth S, Loukola A, Hemminki A, Lothe RA, Stenwig AE et al. Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors. Cancer Res 1998; 58: 2087-2090.
190. Dong SM, Kim KM, Kim SY, Shin MS, Na EY, Lee SH et al. Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in leftsided colon cancer. Cancer Res 1998; 58: 3787-3790.
191. Liu K, Luo Y, Tian H, Yu KZ, He JX, Shen WY. The tumor suppressor LKB1 antagonizes WNT signaling pathway through modulating GSK3beta activity in cell growth of esophageal carcinoma. Tumour Biol 2013; 35: 995-1102.
192. Ekizoglu S, Dalay N, Karaman E, Akdeniz D, Ozaydin A, Buyru N. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer. Transl Res 2013; 162: 122-129.
193. Huang Y, Chen ZK, Huang KT, Li P, He B, Guo X et al. Decreased expression of LKB1 correlates with poor prognosis in hepatocellular carcinoma patients undergoing hepatectomy. Asian Pac J Cancer Prev 2013; 14: 1985-1988.
194. Korsse SE, Harinck F, van Lier MG, Biermann K, Offerhaus GJ, Krak N et al. Pancreatic cancer risk in Peutz-Jeghers syndrome patients: a large cohort study and implications for surveillance. J Med Genet 2013; 50: 59-64.
195. Sato N, Rosty C, Jansen M, Fukushima N, Ueki T, Yeo CJ et al. STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol 2001; 159: 2017-2022.
196. Su GH, Hruban RH, Bansal RK, Bova GS, Tang DJ, Shekher MC et al. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol 1999; 154: 1835-1840.
197. Duivenvoorden WC, Beatty LK, Lhotak S, Hill B, Mak I, Paulin G et al. Underexpression of tumour suppressor LKB1 in clear cell renal cell carcinoma is common and confers growth advantage in vitro and in vivo. Br J Cancer 2013; 108: 327-333.
198. Gonzalez-Sanchez E, Martin-Caballero J, Flores JM, Hernandez-Losa J, Cortes J, Mares R et al. Lkb1 loss promotes tumor progression of BRAF(V600E)-induced lung adenomas. PLoS One 2013; 8: e66933.
199. Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K, Kozlowski P et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 2007; 448: 807-810.
200. Koivunen JP, Kim J, Lee J, Rogers AM, Park JO, Zhao X et al. Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients. Br J Cancer 2008; 99: 245-252.
201. Sanchez-Cespedes M, Parrella P, Esteller M, Nomoto S, Trink B, Engles JM et al. Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res, 2002; 62: 3659-3662.
202. Tanwar PS, Mohapatra G, Chiang S, Engler DA, Zhang L, Kaneko-Tarui T et al. Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer. Carcinogenesis 2013; 35: 546-553.
203. Wang ZJ, Churchman M, Campbell IG, Xu WH, Yan ZY, McCluggage WG et al. Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours. Br J Cancer 1999; 80: 70-72.
204. Avizienyte E, Loukola A, Roth S, Hemminki A, Tarkkanen M, Salovaara R et al. LKB1 somatic mutations in sporadic tumors. Am J Pathol 1999; 154: 677-681.
205. Mack HI, Munger K. The LKB1 tumor suppressor differentially affects anchorage independent growth of HPV positive cervical cancer cell lines. Virology 2013; 446: 9-16.
206. Forster LF, Defres S, Goudie DR, Baty DU, Carey FA. An investigation of the Peutz-Jeghers gene (LKB1) in sporadic breast and colon cancers. J Clin Pathol 2000; 53: 791-793.
207. Sobottka SB, Haase M, Fitze G, Hahn M, Schackert HK, Schackert G. Frequent loss of heterozygosity at the 19p13.3 locus without LKB1/STK11 mutations in human carcinoma metastases to the brain. J Neurooncol 2000; 49: 187-195.
208. Sohn J, Do KA, Liu S, Chen H, Mills GB, Hortobagyi GN et al. Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy. Ann Oncol 2013; 24: 2522-2526.
209. Rowan A, Bataille V, MacKie R, Healy E, Bicknell D, Bodmer W et al. Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas. J Invest Dermatol 1999; 112: 509-511.
210. Guldberg P, thor Straten P, Ahrenkiel V, Seremet T, Kirkin AF, Zeuthen J. Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene 1999; 18: 1777-1780.